Vyne Therapeutics Inc banner

Vyne Therapeutics Inc
NASDAQ:VYNE

Watchlist Manager
Vyne Therapeutics Inc Logo
Vyne Therapeutics Inc
NASDAQ:VYNE
Watchlist
Price: 0.601 USD -0.83% Market Closed
Market Cap: $20m

Wall Street
Price Targets

VYNE Price Targets Summary
Vyne Therapeutics Inc

Wall Street analysts forecast VYNE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VYNE is 3.315 USD with a low forecast of 2.02 USD and a high forecast of 4.725 USD.

Lowest
Price Target
2.02 USD
236% Upside
Average
Price Target
3.315 USD
452% Upside
Highest
Price Target
4.725 USD
686% Upside
Vyne Therapeutics Inc Competitors:
Price Targets

Revenue
Forecast

-2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-2% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 9 years the compound annual growth rate for Vyne Therapeutics Inc's revenue is -2%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VYNE's stock price target?
Price Target
3.315 USD

According to Wall Street analysts, the average 1-year price target for VYNE is 3.315 USD with a low forecast of 2.02 USD and a high forecast of 4.725 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett